Pancreatic Cancer Research

ResearcherAffiliated Hospital of Nantong UniversityActive in the last 2 years

Wei Cao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3863-137X; OpenAlex author ID A5076185144. Sources: OpenAlex.

Their work

Papers
4
Trials
0
Grants
0
Labs led
0
Collaborators
12
Papers, trials and grants by year

2015: 1 paper · 2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 4

  1. [Retracted] Inhibition of 5‑lipoxygenase triggers apoptosis in pancreatic cancer cells. Co-author DOI 10.3892/or.2024.8853↗
  2. LncRNA SNHG12 contributes proliferation, invasion and epithelial-mesenchymal transition of pancreatic cancer cells by absorbing miRNA-320b. Co-author DOI 10.1042/bsr20200805↗
  3. β2-adrenergic receptor signaling promotes pancreatic ductal adenocarcinoma (PDAC) progression through facilitating PCBP2-dependent c-myc expression. Co-author DOI 10.1016/j.canlet.2016.01.026↗
  4. Sp1-driven up-regulation of miR-19a decreases RHOB and promotes pancreatic cancer. Co-author DOI 10.18632/oncotarget.3975↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Guoxiong Zhou · 3 shared papers, 2016–2025 · strength 0.57
  2. Xiaoling Ding · 2 shared papers, 2016–2025 · strength 0.33
  3. Hong Zhang · 1 shared paper, 2025 · strength 0.28
  4. Gong Chen · 1 shared paper, 2016 · strength 0.05
  5. Ying Xiao · 1 shared paper, 2016 · strength 0.05
  6. Aiguo Shen · 1 shared paper, 2016 · strength 0.05
  7. Chunhua Wan · 1 shared paper, 2016 · strength 0.05
  8. Heying Zhang · 1 shared paper, 2015 · strength 0.04
  9. Xianghong Yang · 1 shared paper, 2015 · strength 0.04
  10. Juan Zeng · 1 shared paper, 2015 · strength 0.04
  11. Yonggang Tan · 1 shared paper, 2015 · strength 0.04
  12. Huawei Zou · 1 shared paper, 2015 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.